Nautilus Biotechnology offers a high-throughput, low-cost platform for analyzing and quantifying the human proteome. Founded by Parag Mallick and Sujal Patel in 2016, Nautilus Biotechnology is backed by investors that include AME Cloud Ventures, Andreessen Horowitz, Bezos Expeditions, Bolt Ventures, Defy Ventures, Madrona Venture Group, Perceptive Advisors, and Vulcan Capital and is headquartered in San Carlos.